648412-55-9 Usage
Uses
Used in Synthetic Chemistry:
Methyl 4-bromo-5-cyano-3-methylthiophene-2-carboxylate is used as a synthetic intermediate for the production of various organic compounds. Its unique structure allows for the creation of a wide range of chemical products, making it a valuable component in the field of synthetic chemistry.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Methyl 4-bromo-5-cyano-3-methylthiophene-2-carboxylate is used as a key building block in the synthesis of new drug molecules. Its presence in the molecular structure can contribute to the development of novel therapeutic agents with potential applications in treating various diseases and medical conditions.
Used in Research:
Methyl 4-bromo-5-cyano-3-methylthiophene-2-carboxylate is also utilized in research settings, where it serves as a subject of study for understanding the properties and reactivity of organohalogen compounds. This knowledge can be applied to the development of new synthetic methods and the exploration of potential applications in various scientific fields.
Check Digit Verification of cas no
The CAS Registry Mumber 648412-55-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,8,4,1 and 2 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 648412-55:
(8*6)+(7*4)+(6*8)+(5*4)+(4*1)+(3*2)+(2*5)+(1*5)=169
169 % 10 = 9
So 648412-55-9 is a valid CAS Registry Number.
648412-55-9Relevant academic research and scientific papers
Heterobicyclic pyrazole derivatives as kinase inhibitors
-
Page/Page column 20, (2008/06/13)
Bicyclo-pyrazoles of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in
HETEROBICYCLIC PYRAZOLE DERIVATIVES AS KINASE INHIBITORS
-
Page 52, (2010/02/06)
Bicyclo-pyrazoles of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in
